6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0045 762-25-1-040-0082 -Tucson CMOP KETOCANOZOLE
ID: 36C77025Q0045Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)
Timeline
    Description

    The Department of Veterans Affairs is seeking proposals for the procurement of 27,192 units of Ketoconazole 2% Shampoo, specifically packaged in 120ML bottles, to be delivered to the Tucson CMOP facility in Arizona. This presolicitation notice (Solicitation Number: 36C77025Q0045) outlines the requirement for vendors to submit a complete solicitation package, including a signed SF1449 cover page, a price schedule in Excel format, and proof of state licensure in compliance with the Drug Supply Chain Security Act (DSCSA). The procurement is crucial for ensuring the availability of essential pharmaceuticals for veteran care, with a delivery timeframe of 10 days after receipt of order (ARO) and a closing date for responses set for November 1, 2024, at 09:00 AM Central Time. Interested vendors should direct their inquiries and submissions to Contract Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov or by phone at (913) 684-0134.

    Point(s) of Contact
    Michael W McAlhaneyContracting Specialist
    Michael.McAlhaney@va.gov
    Files
    Title
    Posted
    The document presents a solicitation from the Department of Veterans Affairs Network Contracting Office 15 for pharmaceutical supplies, specifically focusing on the procurement of Ketoconazole 2% Shampoo, with a total estimated quantity of 27,192 units. It outlines submission requirements for quotes, including the need for a signed SF1449 cover page, a price schedule in Excel format, and a state wholesale distributor license for compliance with DSCSA. Delivery specifications detail shipping through USPS and stipulate that all products must include bar code labeling complying with industry standards. The contractor must provide transaction histories and meet specific requirements outlined in various FAR clauses. Additionally, the solicitation emphasizes the importance of drug supply chain security compliance and mandates the acknowledgment of amendments. Key administrative details include invoicing procedures and acceptance terms. The document demonstrates the government’s commitment to veteran care by ensuring the procurement of quality and compliant products while facilitating clear communication and standards for potential contractors.
    The Department of Veterans Affairs is seeking proposals for the procurement of KETOCONAZOLE 2% SHAMPOO, specifically 120ML, with a total quantity of 27,192 units, to be delivered to the Tucson CMOP facility in Arizona. This presolicitation notice (Solicitation Number: 36C77025Q0045) indicates an estimated issue date of October 25, 2024, and the response deadline is set for November 1, 2024, at 09:00 AM Central Time. The acquisition falls under the unrestricted set-aside category, with a delivery timeframe of 10 days after receipt of order (ARO), and it requires vendors to quote shipping expenditures, as the vendor is responsible for delivery costs. Interested vendors must submit a complete solicitation package that includes a signed SF1449 cover page, a price schedule in Excel format, and proof of state licensure in compliance with the Drug Supply Chain Security Act. Quotes must be emailed to the designated contracting specialist. This solicitation underscores the VA's commitment to sourcing pharmaceuticals and ensuring compliance with trade regulations while facilitating reliable support for veterans' healthcare needs.
    The document outlines the Trade Agreements Certificate requirement under federal procurement rules, specifically in relation to U.S.-made and designated country end products for government contracts. The offeror must certify that their products meet the criteria defined in the solicitation. Any products not meeting these criteria must be identified by the offeror, listing their country of origin. The government evaluates bids according to the Federal Acquisition Regulation, giving preference to U.S.-made or designated country products. However, if no qualifying offers are available or the offer is insufficient, alternatives may be considered. This certification is essential in ensuring compliance with trade agreements while promoting domestic manufacturing in federal procurement practices.
    The document outlines a Request for Quotation (RFQ) 36C77025Q0045 issued by the Veterans Affairs (VA) for the procurement of Ketoconazole 2% Shampoo, with an estimated issue date of October 25, 2024, and a closing date of November 1, 2024. The successful vendor is expected to deliver the product by November 21, 2024, and must comply with the Drug Supply Chain Security Act (DSCSA) provisions. Compliance includes submitting a state wholesale distributor license alongside the quote and documentation verifying adherence to the DSCSA, which became effective January 1, 2015. Additionally, the RFQ specifies the required documents, including a signed SF1449 cover page, a price schedule in Excel format, and completion of the Trade Agreements Certificate. Vendors are instructed to submit transaction history and compliance documents via specific VA email addresses, categorizing delivery locations across various VA facilities. The document emphasizes the importance of proper documentation to ensure vendor compliance and successful bidding within the VA procurement framework.
    Similar Opportunities
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0046 770-25-1-801-0022 -National CMOP K0016 KETOCONAZOLE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, through the National CMOP Contracting Office, is seeking to procure Ketoconazole 2% shampoo in various quantities for emergency delivery to multiple Compounding Medication Order Pharmacy (CMOP) facilities across the United States. The procurement includes specific item quantities, with a total of 27,600 units required, emphasizing compliance with the Drug Supply Chain Security Act (DSCSA) and adherence to U.S. trade agreements. This acquisition is crucial for ensuring that veterans receive necessary pharmaceutical products in a timely manner. Interested vendors must submit their quotes by November 1, 2024, with an estimated award date of November 6, 2024, and should direct all inquiries and submissions to Contracting Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov.
    6505--Ketoconazole 2% Cream
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the supply of Ketoconazole 2% Cream, a pharmaceutical product essential for treating various skin conditions. Offerors are required to submit pricing for the base year and four option years, ensuring compliance with the Cost Recovery Fee of 0.5%, and must provide unique National Drug Codes (NDC) for their proposed products. This procurement aims to establish a reliable supply chain for pharmaceutical needs while adhering to federal procurement standards, emphasizing the importance of FDA cGMP compliance for manufacturers or authorized distributors. Interested parties should contact Contract Specialist Michael J Olszewski at Michael.Olszewski@va.gov for further details regarding the solicitation process.
    6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0041 762-25-1-040-0052 -Tucson CMOP 2 PHARMACEUTICALS
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply pharmaceuticals for the Consolidated Mail Outpatient Pharmacy (CMOP) in Tucson, Arizona, under solicitation number 36C77025Q0041. The procurement includes specific quantities of Dorzolamide HCL 2% ophthalmic solution and Zolmitriptan 5mg nasal spray, which are critical for the healthcare services provided to veterans. Compliance with the Drug Supply Chain Security Act (DSCSA) is mandatory, requiring vendors to submit documentation such as a state wholesale distributor license and a completed Trade Agreements Certificate. Interested parties must submit their quotations by October 30, 2024, at 09:00 AM CST, with the anticipated award date set for November 4, 2024. For further inquiries, vendors can contact Contract Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov or (913) 684-0134.
    6505--Betamethasone RFP
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the supply of Betamethasone Dipropionate Cream, a pharmaceutical product essential for the healthcare of veterans. Offerors are required to submit competitive pricing for a base year and four option years, including a mandatory 0.5% Cost Recovery Fee, while ensuring compliance with the Drug Supply Chain Security Act and Good Manufacturing Practices. This contract is vital for maintaining a consistent supply of medications through the VA and Department of Defense's Prime Vendor Programs, emphasizing the government's commitment to providing quality healthcare to service members. Interested vendors should contact Contract Specialist Amber Zavala at amber.zavala@va.gov for further details regarding the solicitation.
    770-25-1-801-0016 -National CMOP NALTREXONE -(VA-25-00010070)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to provide Naltrexone tablets as part of a procurement initiative under solicitation number 36C77025Q0036. Vendors are required to submit their quotes by 4:00 PM CT on October 28, 2024, and must include essential documentation such as a signed SF1449 Solicitation cover page, a completed quote spreadsheet, and compliance with the Drug Supply Chain Security Act. This procurement is critical for ensuring the availability of pharmaceuticals necessary for the healthcare of veterans, reflecting the government's commitment to quality service. Interested vendors can contact Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162 for further information.
    6505--770-25-1-801-0013 - National CMOP CHLORHEXIDINE GLUCONATE 4% TOP LIQUID (VA-24-00109489)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the procurement of CHLORHEXIDINE GLUCONATE 4% TOP LIQUID for the National CMOP facility, under solicitation number VA-24-00109489. Vendors are required to submit a signed SF1449 cover page, a completed pricing schedule, and necessary licensing documents, ensuring compliance with federal regulations, including the Buy American Act and the Drug Supply Chain Security Act. This procurement is critical for providing quality pharmaceutical supplies to veterans, emphasizing the importance of adherence to strict acceptance criteria and logistical requirements. Quotes must be submitted by October 30, 2024, at 3:00 PM Central Time, and interested parties can contact Lacie A Nowak at lacie.nowak@va.gov for further information.
    6505--770-24-4-801-0686 -National CMOP CLINDAMYCIN -(VA-24-00096153)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to provide Clindamycin PO4 1% Top Swab for delivery to multiple Compounding Medication Outpatient Pharmacies (CMOP) across the country. This procurement aims to secure approximately 3,584 units of the specified pharmaceutical product, ensuring compliance with federal regulations and the Drug Supply Chain Security Act (DSCSA). The goods are essential for the VA's healthcare services, supporting the treatment of various medical conditions. Interested vendors must submit their quotations by September 6, 2024, including a signed SF1449 cover page, a price schedule, proof of a valid State Wholesale Distributor License, and a Buy American Act Certificate. For further inquiries, vendors can contact Kelley Cunningham at kelley.cunningham@va.gov or call 913-684-0140.
    6505--Tadalafil Tablets (VA-24-00107372)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79724R0033 concerning the procurement of Tadalafil Tablets, intended for various federal entities, including the Department of Defense and the Bureau of Prisons. The selected contractor will be responsible for ensuring a continuous supply of Tadalafil, with a contract period of one year and four optional annual extensions, and must adhere to specific labeling and packaging requirements, including safety features for the bottles. This procurement is crucial for meeting the medication needs of veterans and other federal healthcare programs, with an estimated total annual requirement of approximately 322,854 bottles across various strengths. Interested parties should direct inquiries to Contract Specialist Billy Fong at billy.fong@va.gov, and proposals are due by November 12, 2024, following the RFP release on or about October 29, 2024.
    6505--CGRP Calcitonin Gene-Related Peptides
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for a contract to supply Calcitonin gene-related peptides (CGRP) as part of its Pharmaceutical Prime Vendor (PPV) Program. The procurement aims to establish a reliable source of these pharmaceutical products, ensuring compliance with federal regulations, including the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP). This initiative is crucial for maintaining consistent supply and quality control across VA medical facilities. Interested offerors must submit their proposals by October 31, 2024, at 2:30 PM CT, and can direct inquiries to Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov.
    6505--Lamotrigine Immediate Release (IR) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Lamotrigine Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care facilities, including the Department of Defense and the Bureau of Prisons. The contract will cover an unrestricted procurement for multiple strengths and packaging sizes of Lamotrigine IR Tablets, with specific requirements for labeling and packaging to ensure compliance with safety standards. This procurement is critical for maintaining the availability of essential medications for veterans and other federal beneficiaries. Interested offerors should note that the solicitation is expected to be released on or about November 7, 2024, with a closing date of November 21, 2024; inquiries can be directed to Contract Specialist Ray Roldan at raymond.roldan@va.gov or by phone at 708-786-4930.